Botanical species · safety record

Soymida febrifuga

The EFSA Compendium of Botanicals holds 9 constituent measurements for Soymida febrifuga. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Soymida febrifuga (Roxb.) A. Juss.

9Constituent measurements

0Safety records

6Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Coumarins	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Isoflavones	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Limonoids	Bark	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Limonoids	Bark	Solvent extraction	0.1 Percent	Unspecified	Resolve DOI
Calcium oxalate	Leaves	Raw, no heat treatment	—	Microscopic detection	No resolvable identifier
Limonoids	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Tannins	Leaves	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Bark	Solvent extraction	≤ 20 Percent	Unspecified	No resolvable identifier
Tannins	Bark	Solvent extraction	≥ 15 Percent	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Awale, Suresh., Miyamoto, Tatsuya., Linn, Thein Zaw., Li, Feng., Win, Nwet Nwet., Tezuka, Yasuhiro., Esumi, Hiroyasu., Kadota, Shigetoshi. Cytotoxic Constituents of Soymida febrifuga from Myanmar. Journal of natural products, 2009, vol. 72, no. 9, p. 1631-1636. DOI
Attarde, D. L., Chaudhari, B. J., Kale, S. S., Bhamber, R. S., Pal, S. C. Pharmacognostic studies on leaflets of Soymida febrifuga Adr. Juss. Family: Meliaceae. Journal of Pharmacy Research, 2010, p. 2435-2440.
Chowdary, P. S., Joseph, K. A., Padmanabhan, K. Soymida febrifuga bark as a suitable substitute for imported wattle bark. Tanner, 1955, p. 15-21.
MALLAVARAPU, GR., MURALIKRISHNA, E., CONNOLLY, JD. 3 TETRANORTRITERPENOIDS FROM FRUITS OF SOYMIDA-FEBRIFUGA. PHYTOCHEMISTRY, 1985, vol. 24, no. 2, p. 305-307.
Yadav, P. Ashok., Suresh, G., Prasad, K. Rajendra., Rao, M. Suri Appa., Babu, K. Suresh. New phragmalin-type limonoids from Soymida febrifttga. TETRAHEDRON LETTERS, 2012, vol. 53, no. 7, p. 773-777. DOI
ADESIDA, GA., TAYLOR, DAH. EXTRACTIVES FROM SOYMIDA-FEBRIFUGA. Phytochemistry, 1972, vol. 11, no. 4, p. 1520-&. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature